What are common barriers to evaluating drug safety data?
You can’t forge the future of medicine with inefficient and error-prone pharmacovigilance oversight. Today’s pharmacovigilance solutions for monitoring and assessment of safety key performance indicators (KPI) should allow users to retrieve applicable information in real-time and in a user-friendly format, with customized data filtering, reporting and analytics for project-specific needs.
How can an analytics dashboard improve your pharmacovigilance monitoring and analysis?
Explore our case study to find out how the Pharmacovigilance Tableau Data Analytics Platform simplified and augmented our partner’s PV process. Continuous access to real-time data helped our partner to modernize their PV solutions to align with the growing expectations for regulatory compliance and comprehensive, real-time case processing. An intuitive, visual analytics platform made it easier to discern actionable insights from drug safety data monitoring and analysis. And, integration with the Argus safety database made it easy for our partner to achieve data extraction, timing and security requirements.
Download our Pharmacovigilance Tableau Data Analytics Platform Case Study
Learn how clients have employed our pharmacovigilance services for intuitive data analysis to:
Subscribe Now
Subscribe Now
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.